NUVA US6707041058

Report

Delayed Nasdaq - 05/27 04:00:00 pm
57.13	USD		+2.46%

05/12	NUVASIVE INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	AQ
05/12	NuVasive, Inc. Announces Management Changes	CI
05/06	Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Rating	MT

Most relevant news about NUVASIVE, INC.

05/12	NuVasive, Inc. Announces Management Changes	CI
05/06	Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..	MT
05/05	RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..	MT
05/05	Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..	MT
05/05	Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating	MT
05/04	NUVASIVE : Q1 Earnings Snapshot	AQ
05/04	NuVasive Logs Upbeat Q1 Results, Lifts FY22 Guidance	MT
05/04	Earnings Flash (NUVA) NUVASIVE Reports Q1 EPS $0.54, vs. Street Est of $0.39	MT
05/04	Earnings Flash (NUVA) NUVASIVE Posts Q1 Revenue $290.8M, vs. Street Est of $277.6M	MT
05/04	TRANSCRIPT : NuVasive, Inc., Q1 2022 Earnings Call, May 04, 2022	CI
05/04	NuVasive Announces First Quarter 2022 Financial Results	PR
05/04	NuVasive, Inc. Revises Earnings Guidance for the Full Year of 2022	CI
05/04	NuVasive, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
04/21	NUVASIVE SIMPLIFY CERVICAL DISC TWO- : Spine	PR
04/21	NUVASIVE, INC. ANNOUNCES THE NUVASIV : Spine	CI

All news about NUVASIVE, INC.

05/12	NUVASIVE INC : Change in Directors or Principal Officers, Submission of Matters to a Vote ..	AQ
05/12	NuVasive, Inc. Announces Management Changes	CI
05/06	Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..	MT
05/05	RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..	MT
05/05	Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..	MT
05/05	Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating	MT
05/04	NUVASIVE : Q1 Earnings Snapshot	AQ
05/04	NuVasive Logs Upbeat Q1 Results, Lifts FY22 Guidance	MT
05/04	Earnings Flash (NUVA) NUVASIVE Reports Q1 EPS $0.54, vs. Street Est of $0.39	MT
05/04	Earnings Flash (NUVA) NUVASIVE Posts Q1 Revenue $290.8M, vs. Street Est of $277.6M	MT

News in other languages on NUVASIVE, INC.

05/12	NuVasive, Inc. annonce des changements de direction
05/04	NuVasive enregistre des résultats optimistes au premier trimestre et revoit ses prévisi..
05/04	Earnings Flash (NUVA) NUVASIVE affiche un chiffre d'affaires de 290,8 millions de dolla..
05/04	NuVasive, Inc. révise ses prévisions de bénéfices pour l'année 2022
05/04	NuVasive, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2022
04/21	NUVASIVE, INC. ANNONCE QUE LES DONNÉ : Spine
04/14	Berkeley Lights nomme Lucas Vitale au nouveau poste de directeur des RH
03/28	Les actions de NuVasive augmentent après que Wells Fargo ait commencé à les couvrir
02/23	NUVASIVE : baisse du BPA ajusté au 4e trimestre, hausse des ventes
02/23	NuVasive, Inc. annonce ses résultats pour l'exercice complet clos le 31 décembre 2021

Analyst Recommendations on NUVASIVE, INC.

05/06	Morgan Stanley Adjusts NuVasive Price Target to $62 From $60, Maintains Equal Weight Ra..	MT
05/05	RBC Capital Adjusts NuVasive's Price Target to $63 From $60, Maintains Outperform Ratin..	MT
05/05	Wells Fargo Adjusts NuVasive's Price Target to $62 From $58, Reiterates Overweight Rati..	MT
05/05	Needham Raises NuVasive's Price Target to $67 From $64, Reiterates Buy Rating	MT
04/13	Truist Securities Adjusts NuVasive's Price Target to $65 From $60, Reiterates Buy Ratin..	MT

Press releases

05/12	NUVASIVE INC : Change in Directors or Principal Officers, Submission of Matters to a Vote ..	AQ
05/04	NUVASIVE : Q1 Earnings Snapshot	AQ
05/04	NUVASIVE INC Management's Discussion and Analysis of Financial Condition and Results o..	AQ
05/04	NUVASIVE INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi..	AQ
05/04	NuVasive Announces First Quarter 2022 Financial Results	PR

Upcoming event on NUVASIVE, INC.

06/03/22

Upcoming sector events

07/21/22	ABBOTT LABORATORIES : Interim 2022 Earnings Release (Projected)
07/28/22	BAXTER INTERNATIONAL INC. : Interim 2022 Earnings Release (Projected)
08/02/22	HOYA CORPORATION : Q1 2022 Earnings Release (Projected)
08/04/22	BECTON, DICKINSON AND COMPANY : Q3 2022 Earnings Release (Projected)

Sector

Healthcare
	Healthcare Services
		Healthcare Equipment & Supplies
			Medical Equipment, Supplies & Distribution
				Other Medical Equipment, Supplies & Distribution